Kezar life sciences, inc. (KZR)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Dec'17
Assets
Current assets:
Cash and cash equivalents

20,571

14,951

20,365

13,031

18,470

24,182

39,594

101,973

51,033

Marketable securities

102,779

63,255

64,878

80,392

82,664

83,250

73,161

16,412

-

Prepaid expenses

2,122

1,878

2,462

1,653

1,664

1,884

1,676

1,538

785

Other current assets

1,060

1,048

1,098

1,160

991

489

894

661

508

Total current assets

126,532

81,132

88,803

96,236

103,789

109,805

115,325

120,584

52,326

Restricted cash

-

-

-

-

-

-

-

-

13

Property and equipment, net

4,131

4,282

4,509

4,713

4,846

4,595

4,660

4,805

1,540

Operating lease right-of-use asset

3,699

3,817

3,929

4,036

4,139

-

-

-

-

Other assets

282

282

282

282

282

282

282

282

343

Total assets

134,644

89,513

97,523

105,267

113,056

114,682

120,267

125,671

54,222

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable

1,583

823

824

955

1,448

193

662

1,105

547

Accrued liabilities

4,202

4,218

3,560

2,858

2,406

2,678

2,345

2,007

911

Operating lease liabilities, current

934

900

868

835

804

-

-

-

-

Deferred rent, current

-

-

-

-

-

354

343

332

-

Other liabilities, current

52

62

75

87

100

112

152

158

26

Total current liabilities

6,771

6,003

5,327

4,735

4,758

3,337

3,502

3,602

1,484

Operating lease liabilities, noncurrent

5,219

5,464

5,699

5,929

6,153

-

-

-

-

Deferred rent, noncurrent

-

-

-

-

-

2,548

2,638

2,728

494

Total liabilities

11,990

11,467

11,026

10,664

10,911

5,885

6,140

6,330

1,978

Redeemable convertible preferred stock, $0.001 par value, zero and 75,533,240 shares authorized as of December 31, 2018 and 2017, respectively; zero and 12,263,126 shares issued and outstanding as of December 31, 2018 and 2017, respectively

-

-

-

-

-

-

-

-

77,931

Stockholders' equity:
Common stock, $0.001 par value, 125,000,000 shares authorized as of March 31, 2020 (unaudited) and December 31, 2019; 38,176,462 and 19,208,077 shares issued and outstanding as of March 31, 2020 (unaudited) and December 31, 2019, respectively

38

19

19

19

19

19

19

19

1

Preferred stock, $0.001 par value, 10,000,000 shares authorized, zero shares issued and outstanding as of March 31, 2020 (unaudited) and December 31, 2019

-

-

-

-

-

-

0

0

-

Additional paid-in capital

217,032

162,505

161,405

160,295

159,093

158,176

157,681

157,192

451

Accumulated other comprehensive loss

-122

-196

-224

-156

-130

-203

-160

-120

-111

Accumulated deficit

-94,300

-84,282

-74,703

-65,555

-56,837

-49,195

-43,413

-37,750

-26,028

Total stockholders' equity

122,654

78,046

86,497

94,603

102,145

108,797

114,127

119,341

-25,687

Total liabilities and stockholders' equity

134,644

89,513

97,523

105,267

113,056

114,682

120,267

125,671

54,222